According to Med City News, “Minneapolis’ CVRx has raised $46 million from unnamed investors in support of its implantable neuromodulator to treat high blood pressure and heart failure, bringing its total equity funding to $237 million over 5 rounds.”  For more information, please visit: http://medcitynews.com/2016/06/cvrx-neuromodulators-for-heart-failure/